Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC
G Mantovani, A Macciò, R Versace, et al.
Virchows Archiv : an International Journal of Pathology
|
April 27, 2000
Peripheral papillary tumor of type-II pneumocytes: a rare neoplasm of undetermined malignant potential
E Dessy, P Braidotti, B Del Curto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer
G Mantovani, A Macciò, P Lai, et al.
International Journal of Cancer
|
May 29, 1997
Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines
G Mantovani, A Macciò, M Pisano, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC
G Mantovani, A Macciò, R Versace, et al.
Virchows Archiv : an International Journal of Pathology
|
April 27, 2000
Peripheral papillary tumor of type-II pneumocytes: a rare neoplasm of undetermined malignant potential
E Dessy, P Braidotti, B Del Curto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 4, 2000
Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer
G Mantovani, A Macciò, P Lai, et al.
International Journal of Cancer
|
May 29, 1997
Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines
G Mantovani, A Macciò, M Pisano, et al.
Page
of 2